CordenPharma nomme le Dr Jean-Luc Herbeaux au poste de directeur général pour mener la prochaine phase de croissance

Positive

AI Analysis

Summary

CordenPharma appoints Dr. Jean-Luc Herbeaux as chief executive officer effective October 1, 2026, with outgoing CEO Dr. Michael Quirmbach transitioning to board member and senior advisor roles.

Importance:2/10

Sentiment:

0.30

management changeCEO appointmentleadership transition

Read the original article

Published by PR Newswire Biotech on September 15, 2026 7:09 PM

Read Original